Free Trial
→ Could TSLA reach $500 a share? Free ebook says it’s possible. (From WealthPress) (Ad)

The 12 Most-Hated Stocks on Wall Street - 11 of 12

Slide 11
Back to 10
Continue to 12
 
Back to 10
Continue to 12
 

Global Payments (NYSE:GPN)

Number of Downgrades
21 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.5
Ratings Breakdown
15 Buy Ratings, 10 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$136.50 (28.6% Upside)

About Global Payments

Global Payments logoGlobal Payments Inc provides payment technology and software solutions for card, check, and digital-based payments in the Americas, Europe, and the Asia-Pacific. It operates through two segments, Merchant Solutions and Issuer Solutions. The Merchant Solutions segment offers authorization, settlement and funding, customer support, chargeback resolution, terminal rental, sales and deployment, payment security, and consolidated billing and reporting services. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/31/2024Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$143.00 ➝ $130.00
10/29/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$118.00 ➝ $115.00
10/22/2024Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$135.00 ➝ $112.00
10/18/2024StephensLower Price TargetOverweight ➝ Overweight$130.00 ➝ $125.00
10/16/2024Jefferies Financial GroupLower Price TargetBuy ➝ Buy$130.00 ➝ $120.00
10/4/2024Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$158.00 ➝ $143.00
10/1/2024OppenheimerInitiated CoverageMarket Perform
9/30/2024BarclaysLower Price TargetOverweight ➝ Overweight$145.00 ➝ $120.00
9/25/2024Morgan StanleyLower Price TargetOverweight ➝ Overweight$164.00 ➝ $156.00
9/25/2024BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$126.00 ➝ $122.00
Slide 11
Back to 10
Continue to 12
 

NASDAQ traded stock with a BIG short position. (Ad)

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

More From MarketBeat
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
7 Housing Stocks to Buy Regardless of Interest Rate Changes
According to the Bankrate survey of large lenders, the average interest rate on a 30-year fixed-rate mortgage ...
MarketBeat
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...
Priority Gold | Sponsored
How to Invest In Growth Stocks
The stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a sto...
MarketBeat
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
7 Flying Car Stocks for Your 2024 Watchlist
Flying cars have been one of the more intriguing investments for speculative investors in the last 12 months. ...
MarketBeat